Occudo Quantitative Strategies LP Tango Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.93 - $11.26 $41,298 - $158,709
14,095 New
14,095 $158,000
Q3 2022

Nov 14, 2022
BUY
$3.25 - $5.46 $33,946 - $57,029
10,445 Added 94.31%
21,520 $78,000
Q2 2022

Aug 15, 2022
BUY
$3.86 - $8.01 $42,749 - $88,710
11,075 New
11,075 $50,000

Others Institutions Holding TNGX

# of Institutions
123
Shares Held
91.7M
Call Options Held
3.1K
Put Options Held
1.5K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $359M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email